Logo image of CENX

CENTURY ALUMINUM COMPANY (CENX) Stock Fundamental Analysis

NASDAQ:CENX - Nasdaq - US1564311082 - Common Stock - Currency: USD

17.29  +0.49 (+2.92%)

After market: 17 -0.29 (-1.68%)

Fundamental Rating

4

Overall CENX gets a fundamental rating of 4 out of 10. We evaluated CENX against 153 industry peers in the Metals & Mining industry. There are concerns on the financial health of CENX while its profitability can be described as average. CENX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CENX had positive earnings in the past year.
CENX had a negative operating cash flow in the past year.
In the past 5 years CENX reported 4 times negative net income.
In multiple years CENX reported negative operating cash flow during the last 5 years.
CENX Yearly Net Income VS EBIT VS OCF VS FCFCENX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

The Return On Assets of CENX (16.43%) is better than 94.77% of its industry peers.
CENX has a better Return On Equity (45.90%) than 97.39% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.46%, CENX is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CENX is significantly below the industry average of 8.53%.
The 3 year average ROIC (3.18%) for CENX is below the current ROIC(6.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.43%
ROE 45.9%
ROIC 6.46%
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
CENX Yearly ROA, ROE, ROICCENX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Profit Margin of CENX (14.35%) is better than 83.66% of its industry peers.
CENX has a Operating Margin (5.47%) which is in line with its industry peers.
CENX's Operating Margin has improved in the last couple of years.
CENX has a worse Gross Margin (8.33%) than 60.78% of its industry peers.
CENX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.47%
PM (TTM) 14.35%
GM 8.33%
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
CENX Yearly Profit, Operating, Gross MarginsCENX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CENX is destroying value.
CENX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CENX has been increased compared to 5 years ago.
The debt/assets ratio for CENX is higher compared to a year ago.
CENX Yearly Shares OutstandingCENX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CENX Yearly Total Debt VS Total AssetsCENX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.10, we must say that CENX is in the distress zone and has some risk of bankruptcy.
CENX's Altman-Z score of 1.10 is on the low side compared to the rest of the industry. CENX is outperformed by 69.28% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that CENX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.67, CENX is doing worse than 81.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.64
WACC10.18%
CENX Yearly LT Debt VS Equity VS FCFCENX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CENX has a Current Ratio of 1.73. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
CENX has a Current ratio of 1.73. This is in the lower half of the industry: CENX underperforms 63.40% of its industry peers.
A Quick Ratio of 0.57 indicates that CENX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.57, CENX is doing worse than 83.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.57
CENX Yearly Current Assets VS Current LiabilitesCENX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 254.84% over the past year.
CENX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.60%.
Measured over the past years, CENX shows a small growth in Revenue. The Revenue has been growing by 3.87% on average per year.
EPS 1Y (TTM)254.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
Revenue 1Y (TTM)1.6%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%23.17%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.41% yearly.
The Revenue is expected to grow by 10.44% on average over the next years. This is quite good.
EPS Next Y188.85%
EPS Next 2Y48.09%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue Next Year10.48%
Revenue Next 2Y6.98%
Revenue Next 3Y10.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CENX Yearly Revenue VS EstimatesCENX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CENX Yearly EPS VS EstimatesCENX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.72, which indicates a correct valuation of CENX.
CENX's Price/Earnings ratio is rather cheap when compared to the industry. CENX is cheaper than 85.62% of the companies in the same industry.
CENX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.22.
A Price/Forward Earnings ratio of 5.44 indicates a rather cheap valuation of CENX.
Based on the Price/Forward Earnings ratio, CENX is valued cheaply inside the industry as 97.39% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.86, CENX is valued rather cheaply.
Industry RankSector Rank
PE 15.72
Fwd PE 5.44
CENX Price Earnings VS Forward Price EarningsCENX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CENX is valued a bit cheaper than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.03
CENX Per share dataCENX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

CENX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX's earnings are expected to grow with 62.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y48.09%
EPS Next 3Y62.41%

0

5. Dividend

5.1 Amount

No dividends for CENX!.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (5/2/2025, 8:00:00 PM)

After market: 17 -0.29 (-1.68%)

17.29

+0.49 (+2.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners58.39%
Inst Owner Change0.06%
Ins Owners1.08%
Ins Owner Change0.29%
Market Cap1.60B
Analysts84.44
Price Target23.8 (37.65%)
Short Float %11.37%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.28%
Min EPS beat(2)7.95%
Max EPS beat(2)124.6%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.36%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)20.06%
Revenue beat(4)2
Avg Revenue beat(4)6.75%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)20.06%
Revenue beat(8)6
Avg Revenue beat(8)6.86%
Revenue beat(12)7
Avg Revenue beat(12)3.73%
Revenue beat(16)7
Avg Revenue beat(16)1.6%
PT rev (1m)-6.67%
PT rev (3m)1.45%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)38.75%
EPS NY rev (1m)24.6%
EPS NY rev (3m)76.49%
Revenue NQ rev (1m)-4.08%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.93%
Revenue NY rev (3m)3%
Valuation
Industry RankSector Rank
PE 15.72
Fwd PE 5.44
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.3
EV/EBITDA 10.03
EPS(TTM)1.1
EY6.36%
EPS(NY)3.18
Fwd EY18.38%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS24.06
BVpS7.52
TBVpS7.52
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.43%
ROE 45.9%
ROCE 8.23%
ROIC 6.46%
ROICexc 6.61%
ROICexgc 6.61%
OM 5.47%
PM (TTM) 14.35%
GM 8.33%
FCFM N/A
ROA(3y)4.38%
ROA(5y)-1.26%
ROE(3y)10.09%
ROE(5y)-6.4%
ROIC(3y)3.18%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)3.31%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3Y6.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.18%
ROICexc growth 5YN/A
OM growth 3Y20%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.87%
GM growth 5YN/A
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 100.61%
Cap/Sales 3.71%
Interest Coverage 3.37
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.57
Altman-Z 1.1
F-Score4
WACC10.18%
ROIC/WACC0.64
Cap/Depr(3y)115.12%
Cap/Depr(5y)92.4%
Cap/Sales(3y)3.72%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)254.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
EPS Next Y188.85%
EPS Next 2Y48.09%
EPS Next 3Y62.41%
EPS Next 5YN/A
Revenue 1Y (TTM)1.6%
Revenue growth 3Y0.12%
Revenue growth 5Y3.87%
Sales Q2Q%23.17%
Revenue Next Year10.48%
Revenue Next 2Y6.98%
Revenue Next 3Y10.44%
Revenue Next 5YN/A
EBIT growth 1Y287.86%
EBIT growth 3Y20.15%
EBIT growth 5YN/A
EBIT Next Year248.74%
EBIT Next 3Y66.3%
EBIT Next 5YN/A
FCF growth 1Y-1108.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.29%
OCF growth 3YN/A
OCF growth 5YN/A